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Abstract Treatment of human colorectal carcinoma cells HT29 
with specific antisense oligodeoxynucleotides led to a decreased 
Galßl ,4GlcNAc oc2,6 sialyltransferase activity on the level of 
protein expression as well as on the mRNA level. Antisense 
treatment did not effect cell viability or cell growth. Oligodeoxy-
nucleotides which were complementary to the region upstream of 
the initiation codon were particularly effective in inhibition of 
enzyme expression. No such inhibition was found by treatment of 
cells with oligodeoxynucleotides complementary to the region 
downstream of the initiation codon or by treatment of cells with 
scrambled controls or sense oligodeoxynucleotides. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Tumor-associated alterations of cell surface glycosylation 
play a crucial role for adhesion and metastasis of carcinoma 
cells. Of particular interest are the sialyltransferases, a group 
of anabolic enzymes which transfer the negatively charged 
carbohydrate sialic acid onto different glycoproteins and gly-
colipids. H u m a n Galß l ,4GlcNAc oc2,6 sialyltransferase 
(a2,6ST), which is only slightly expressed in normal colonie 
mucosa cells, shows an enhanced activity in metastasizing 
colorectal carcinomas [1-3]. Hypersialylation due to enhanced 
enzyme activity may lead e.g. to reduced cell-cell adhesion [4] 
and/or increased adhesion of tumor cells to the basal mem-
brane [5] and may hamper immune response mechanisms [6]. 
As a first step towards an understanding of the functional 
relevance of oc2,6ST, we tried to inhibit enzyme expression 
by treatment of human colorectal cancer cells with specific 
antisense oligodeoxynucleotides (ODN). 
2. Material and methods 
2.1. Oligodeoxynucleotide (ODN) synthesis 
ODNs were synthesized in 40 nm lots using an Applied Biosystems 
380B automated DNA synthesizer and HPLC purified (BioTez, Ber-
lin-Buch). Sequences were complementary to the region next to the 
initiation codon of human 2,6ST-cDNA [7,8] (Table 1). All ODNs 
were synthesized as phosphorothioates. Instead of thymidine C-5 pro-
pynyl-2'-deoxyuridine was used as described [9]. 
2.2. Treatment of HT29 human colorectal carcinoma cells with ODNs 
Cells (5X 104/ml) were seeded into 6-well tissue culture plates and 
grow until just confluent in DMEM (Biochrom, Germany), 7% FCS, 
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5% CO2. Approximately 1.5 X 106 cells per well were counted. The cell 
monolayer was carefully washed with 2 X 5 ml DMEM without FCS, 
then 2 ml (10 ug/ml) Lipofectin (GIBCO) in DMEM without FCS 
was added and cells were incubated for 2 h at 37°C. ODNs were 
heated 20 min at 70°C and renatured 15 min at 22°C before dilution. 
Then 2 ml of a ODN solution in DMEM containing Lipofectin as 
described above was added to the cells. After a 4 h incubation at 
37°C, 4 ml medium containing 14% FCS was added and cells were 
incubated for another two days at 37°C, 5% CO2. Cell growth was 
determined using the MTT (3-[4,5-dimethylthiazol-2yl])-2,5-diphenyl-
tetrazolium bromide) assay (Sigma) according to standard protocols. 
Each ODN experiment was repeated at least three times in duplicates. 
2.3. Fluorometric sialyltransferase assay 
Monolayers of cells, untreated or treated with 2 uM, 1 uM ODN in 
6-well plates were washed with ice-cold phosphate-buffered saline 
(PBS), pH 7.3, at 4°C for a total period of 5 min to remove unbound 
ODN. Washes were completely removed by aspiration. The remaining 
cell sheet was incubated on a rocking plate for 30 min at 4°C in 500 ul 
0.25 M sodium cacodylate buffer (Roth, Germany), pH 6.5, contain-
ing 0.4% Triton-X-100 (Sigma). Supernatants were centrifuged at 
20000Xg, 4°C for 20 min. Protein content in diluted supernatants 
was determined by BIO-RAD (München) protein assay using bovine 
serum albumin as standard. Enzyme activity was measured fluoromet-
rically according to [10]. Briefly, 5 ul enzyme extract containing 5 ug 
protein was incubated with 5 ul of 0.25 M sodium cacodylate buffer, 
pH 6.5, 1.3 ul acceptor HPLC-purified asialo-al-acid glycoprotein (25 
mg/ml) (Sigma), 1.4 ul 350 uM CMP-9-fluoresceinyl-NeuAc (Boeh-
ringer-Mannheim) and 7.3 ul H2O for 30 min at 37°C. Reaction was 
stopped by addition of 2.7 ul CTP (Sigma). Ten microliters of the 
assay mixture were applied to a liquid chromatography system. Fluo-
rescence was detected at an excitation wavelength of 490 nm and an 
emission wavelength of 520 nm. Separation of fluorescently labeled 
glycoprotein from donor substrate was performed on an column 
(12.5X0.4 cm) of Sephadex G50 (Pharmacia) operated isocratically 
with 0.1 M Tris/HCl, pH 8.5 at 0.5 ml/min. As control experiments, 
similar assays were performed with 0.5 |j.U to 0.025 uU rat liver a2,6 
sialyltransferase (Boehringer-Mannheim). Endogenous activity (after 
incubation without acceptor asialo-al-acid glycoprotein) was sub-
tracted. 
2.4. Radiometrie sialyltransferase assay 
Sialyltransferase was extracted as shown above. Standard assay 
(100 (il) was performed with 50 ug protein extract and 1.25 mg N-
acetyllactosamine (Dextra, UK) in 50 mM sodium cacodylate, pH 6.4, 
containing 375 ug bovine serum albumin (BSA), 0.25 mM CDP-chol-
ine, 0.25 mM MnCl2, 0.1% Triton-X-100 and 0.5 mM PMSF. Trans-
fer was initiated by addition of 10 nmol CMP-NeuAc (Boehringer-
Mannheim), containing CMP-[3H]-NeuAc (Du Pont) with an activity 
of 3700 Bq (70 000 cpm). After incubation for up to 300 min at 37°C, 
the sample was boiled for 5 min at 95°C, centrifuged (20000Xg) and 
filtered. Separation of 6'- and 3'-sialyl-N-acetyllactosamine isomers 
on a NH2-Lichrosorb column (Merck, Darmstadt, Germany) was 
done as described [2]. Briefly, chromatography was run isocratically 
with 83/17 (v/v) acetonitrile/15 mM KH 2P0 4 for 40 min, then the 
proportion of the mixture was changed to 78/22. Fractions of 3 ml 
were collected and radioactivity counted by liquid scintillation spec-
trometry in Ultima Gold. One unit of activity is defined as the amount 
of enzyme catalyzing the formation of 1 umol product/min. 
2.5. RT-PCR for a2,6ST mRNA 
Monolayers of cells, untreated or treated with 2 uM, 1 uM ODN in 
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6-well plates were washed with ice-cold PBS, pH 7.3, at 4°C for a total 
period of 5 min to remove unbound ODN. Washes were completely 
removed by aspiration. RNA was extracted from the remaining cell 
sheet using guanidine thiocyanate-phenol-chloroform (GIBCO) ac-
cording to [11] and treated with RNase-free DNase (Boehringer-Man-
nheim). Five micrograms of total cellular RNA were reverse tran-
scribed by M-MLV reverse transcriptase (ProMega) with random 
hexamers (Pharmacia). CDNA was amplified using a2,6ST-specific 
primers: forward primer ST181, CTGCCCAAGGAGAGCATTAG; 
forward primer ST379, AAAAACCTTATCCCTAGGCTGC; reverse 
primer STrev, TGGTAGTTTTTGTGCCCACA. ß-Actin was co-am-
plified within the same tube using forward primer actinl, 
TGACGGGGTTCACCCACACTGTGCCCATCT; reverse primer 
actin2, AGTCATAGTCCGCCTAGAAGCATTTGCGGT. Amplifi-
cation was done using hot start PCR (5 min at 94°C). Cycling con-
ditions were 1 min at 94°C, 1 min at 57°C, 2 min at 72°C for 30 
cycles. PCR reaction mixture contained 1.5 ill PCR-buffer (100 mM 
Tris-HCl pH 8.3, 500 mM KC1, 15 mM MgCl2 with 0.1% gelatine (w/ 
v)), 5 ul cDNA, 1.5 Lil 2 mM of dATP, dCTP, dGTP, dTTP (Phar-
macia), 50 pmol a2,6ST-specific primers and 0.4 pmol ß-actin primers, 
0.1 ul Taq Polymerase (Perkin-Elmer) and H 2 0 ad 15 ill. PCR-prod-
ucts were electrophoresed in 3% agarose (Roth, Germany) containing 
ethidium-bromide (GIBCO). For fluorescence measurements Fluor-
Imager SI (Molecular Dynamics) was used. The coefficient of varia-
tion among several measurements of the same sample was less than 
3%. 
3. Results 
Fig. 1. RT-PCR of a2,6ST mRNA in HT29 cells treated with AS 7. 
HT29 cells were incubated with 2 uM, 1 uM antisense ODN or re-
main untreated (control). Images were obtained by fluorescence 
scanning of electrophoretically resolved, ethidium bromide-stained 
PCR products derived from co-amplification of ß-actin (upper lanes) 
and a2,6ST (lower lanes) target sequences. 
3.1. Effects of ODN treatment on cell growth 
Incubation of HT29 cells with O D N Scramble 2 (Table 1) 
in concentrations of up to 4 u\M did not effect cell growth as 
detected by MTT-Test . Treatment of HT29 cells with a 4 u M 
O D N solution of Scramble 2 decreased the number of cells to 
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Fig. 2. Effect of antisense-ODN treatment on a2,6ST mRNA level. HT29 cells were incubated with 2 uM, 1 uM antisense ODN or remain un-
treated (control). a2,6ST mRNA was detected by RT-PCR with specific primers. Fluorescence of electrophoretically resolved, ethidium bro-
mide-stained PCR products of ß-actin and tx2,6ST target sequences was determined for each treatment. Semi-quantitative analysis was done by 
comparison with ß-actin co-amplified within the same tube. For each ODN experiment, a2,6ST mRNA level was compared with co-amplified 
ß-actin and expressed as percent of the ratio of the untreated control (= 100%). Untreated controls showed 25 ± 12% of ß-actin fluorescence. 
Each value represents the mean ± SD of at least three determinations. 
W. Kemmner et al.lFEBS Letters 409 (1997) 347-350 349 
B 2 M M 01 MM 
c o o 
■o 
II 
"l ■ I 
I 
II 
ODN # 
Fig. 3. Effect of antisense-ODN treatment on sialyltransferase activity. HT29 cells were incubated with 2 uM, 1 |xM antisense ODN or remain 
untreated (control). Enzyme activity was determined by fluorometric sialyltransferase assay using asialo-alGP as acceptor. Enzyme activity is 
expressed as percentage of total activity of untreated controls (100%). One hundred percent was 0.096 ±0.012 u.U. Each value represents the 
mean ± SD of at least three determinations. 
96 ± 6% of that of untreated cells. Treatment with a 8 uM 
solution of Scramble 2 decreased cell number to 78 ± 7% of 
that of untreated controls. 
3.2. Effects of ODN treatment on o2,6ST-mRNA 
RT-PCR of RNA extracted from HT29 cells treated with 
antisense ODN AS 7 produced an a2,6ST band displaying 
less fluorescence compared with untreated controls (Fig. 1). 
Co-amplification of ß-actin within the same tubes produced 
bands with a similar density in untreated controls and anti-
sense-treated cells. 
Density of each a2,6ST band was compared with the ap-
propriate ß-actin band amplified within the same tube by 
calculating the ratio : (Fluorescence units of oc2,6ST/Fluores-
cence units of ß-actin) X 100. The detection limit of the fluo-
rometric measurements was about 1 ng double-stranded 
DNA. The linear portion of this assay ranges up to 25 ng. 
Standard derivation between triplicate measurements was on 
an average 24%. The results show that incubation of HT29 
cells with antisense-ODN AS 7 in a concentration of 2 |iM 
reduced cc2,6ST mRNA level down to 16 ± 8% of the mRNA 
level of untreated controls (Fig. 2). 
3.3. Effects of ODN treatment on u2,6ST enzyme activity 
Incubation of HT29 cells with antisense-ODNs in a concen-
tration of 2 u\M reduced fluorometrically determined sialyl-
transferase enzyme activity down to 56 ± 7% in the case of 
AS 7 (Fig. 3). No such inhibition of enzyme activity was 
Table 1 
Design of oligodeoxynucleotides synthesized for inhibition of a2,6ST expression 
AS Sequence 
1 
2 
3 
4 
5 
6 
7 
8 
Scramble 1 
Scramble 2 
Sense 
AG GUU 
OÜ 
Ü 
GGU 
GGU 
GGU 
GUG 
GUG 
GUG 
GUG 
AGU 
GAG 
ACA 
AAU 
AAU 
AAU 
AAU 
AAU 
GAU 
UGU 
UCU 
CAU 
CAÜ 
CAU 
CAU 
CAU 
CAU 
CAU 
CAU 
CUA 
AAC 
UCA 
AAU 
AAU 
AAU 
AAU 
AAU 
AAU 
AAU 
UAG 
UAU 
UUA 
GAA 
GAA 
G 
GAA 
GAA 
GAA 
GAA 
A 
AAG 
ÜGA 
G 
GA 
GA 
GAU 
GAU 
GAU 
CUG 
UUC 
GUG 
GUG 
GUG 
UGA 
ACA 
UUC 
UUC AGG 
In bold letters the codon complementary to the initiation codon is depicted. U means C-5 propynyl-2'-deoxyuridin. Scramble 1 contains the same 
content in A, C, G, U as AS 4 but in a random order. Scramble 2 contains the same content in A, C, G, U as AS 8 but in a random order. Sense is 
a sense version with A UG in the middle of the sequence. 
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found after incubation of cells with AS 1, AS 2, AS 3, 
scrambled or sense sequences. Radiometrie measurements, 
which allow to differentiate between oc2,3ST and a2,6ST ac-
tivity, showed that cc2,6ST was decreased to 62 ±5% after 
treatment of cells with 2 uM AS 7, but that oc2,3ST activity 
was similar to that of untreated controls. 
4. Discussion 
Incubation of HT29 cells with 2 uM antisense-ODN led to 
a striking decrease of oc2,6ST activity on the mRNA level as 
well as on the level of protein expression. Antisense treatment 
had no effect on cell viability or cell growth up to a concen-
tration of 4 uM. ODNs which were complementary to the 
region upstream of the initiation codon of the a2,6ST 
mRNA (AS 6, AS 7, AS 8) were particularly effective in in-
hibiting enzyme expression. No inhibition on the level of the 
mRNA as well as on the level of protein expression was found 
by treatment of cells with ODNs complementary to the region 
downstream of the initiation codon, or by treatment of cells 
with scrambled or sense ODNs. Length of ODNs seems to 
influence their inhibitory potential, since the 18-mer AS 7 
inhibits enzyme expression stronger than AS 8 (21-mer) or 
AS 6 (15-mer) with similar sequences. Inhibition of a2,6ST 
was stronger on the mRNA level than on the level of enzyme 
activity, presumably due to the longer half-life of enzyme 
proteins vs. RNA. 
This is the first time that the expression of a glycoprotein-
specific glycosyltransferase has been inhibited with antisense-
ODNs. Similar treatment of human promyelocytic line HL-60 
with antisense-ODNs to ganglioside glycosyltransferases has 
effectively down-regulated ganglioside biosynthesis [12]. Fu-
ture experiments will show whether it is possible to reduce 
tumor cell surface sialylation in this way. Then functional 
studies will be possible with the aim to obtain antisense-
ODNs suitable for the clinical treatment of metastasis. 
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